Ligand validation:6ETW

BX5: [4-(2~{H}-1,2,3,4-tetrazol-5-yl)butanoylamino]azanium

BX5 is a Ligand Of Interest in 6ETW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ETW_BX5_A_410	52%	3%	0.124	0.88	3.01	3.39	4	5	0	0	100%	0.86

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.